Universe · entity
Foresite Capital Management V, LLC
Institutional manager (13F) · CIK 1792206
13F holdings · as of 2026-03-31 · top 9 · reported portfolio $271M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | ALUMIS INC. | $130M | 5,896,995 |
| 2 | CG Oncology, Inc. | $68M | 1,004,050 |
| 3 | Disc Medicine, Inc. | $24M | 374,069 |
| 4 | Hims & Hers Health, Inc. | $15M | 738,151 |
| 5 | Eikon Therapeutics, Inc. | $14M | 1,318,983 |
| 6 | Lyell Immunopharma, Inc. | $10M | 477,078 |
| 7 | Pharvaris N.V. | $5M | 194,125 |
| 8 | Nurix Therapeutics, Inc. | $4M | 265,000 |
| 9 | Maze Therapeutics, Inc. | $773k | 25,905 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.